Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Bewilderment

fluorodeoxyglucose f18 has been researched along with Bewilderment in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fanale, CM; Melrose, RJ; Sultzer, DL; Veliz, JV; Weissberger, GH1
Dombernowsky, NW; Hasselbalch, SG; Law, I1
Chiou, SM; Hsu, YT; Huang, HY; Kao, CH; Tsai, CH; Tsai, MC; Wu, YC1

Other Studies

3 other study(ies) available for fluorodeoxyglucose f18 and Bewilderment

ArticleYear
Cortical Metabolic and Cognitive Correlates of Disorientation in Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognition Disorders; Confusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Tomography Scanners, X-Ray Computed

2017
[Confusion, loss of consciousness and unspecific visual hallucinations may be symptoms of dementia with Lewy bodies].
    Ugeskrift for laeger, 2018, Sep-17, Volume: 180, Issue:38

    Topics: Aged, 80 and over; Confusion; Female; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Body Disease; Positron-Emission Tomography; Unconsciousness

2018
Zolpidem improves neuropsychiatric symptoms and motor dysfunction in a patient with Parkinson's disease after deep brain stimulation.
    Acta neurologica Taiwanica, 2012, Volume: 21, Issue:2

    Topics: Confusion; Deep Brain Stimulation; Female; Fluorodeoxyglucose F18; Humans; Hypnotics and Sedatives; Magnetic Resonance Imaging; Middle Aged; Motor Activity; Parkinson Disease; Positron-Emission Tomography; Psychiatric Status Rating Scales; Pyridines; Subthalamus; Zolpidem

2012